![Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects Björn Pasternak; Anders Hviid R3 Jungwook. - ppt download Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects Björn Pasternak; Anders Hviid R3 Jungwook. - ppt download](https://images.slideplayer.com/42/11374774/slides/slide_3.jpg)
Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects Björn Pasternak; Anders Hviid R3 Jungwook. - ppt download
![Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial | Reproductive Health | Full Text Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial | Reproductive Health | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12978-017-0292-7/MediaObjects/12978_2017_292_Fig1_HTML.gif)
Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial | Reproductive Health | Full Text
Infant Safety during and after Maternal Valacyclovir Therapy in Conjunction with Antiretroviral HIV-1 Prophylaxis in a Randomize
![PDF) A Randomised Placebo Controlled Trial of Suppressive Acyclovir in Late Pregnancy in Women with Recurrent Genital Herpes Infection PDF) A Randomised Placebo Controlled Trial of Suppressive Acyclovir in Late Pregnancy in Women with Recurrent Genital Herpes Infection](https://i1.rgstatic.net/publication/51325380_A_Randomised_Placebo_Controlled_Trial_of_Suppressive_Acyclovir_in_Late_Pregnancy_in_Women_with_Recurrent_Genital_Herpes_Infection/links/5a138b860f7e9b1e57308eba/largepreview.png)